Abstract
Osteoporosis is frequently seen in systemic mastocytosis. Although diphosphonate therapy has been shown to be transiently effective, therapy options for this form of osteopenia are very limited. We have treated three patients with systemic mastocytosis and osteopenia successfully with intrferon alpha-2b. Two patients had urticaria pigmentosa and two severe back pain due to vertebral compression fractures. All patients received a daily interferon dose of 3 x 5 mio units/week s.c. for a period of 6 months. Therapy was well tolerated, and back pain resolved in both patients. A marked decrease of mast cell numbers in the bone marrow and a significant increase of bone mineralization and bone density was observed in all patients. Our data suggest that alpha interferon may be a new treatment option for osteopenia in systemic mastocytosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bardin T, Lequesne M (1989) The osteoporosis of heparinotherapy and systemic mastocytosis. Clin Rheumatol 8:119–123
Cundy T, Beneton MNC, Darby AJ, et al (1987) Osteopenia in systemic mastocytosis: natural history and responses to treatment with inhibitors of bone resorption. Bone 8:149–155
De-Gennes C, Kuntz D, De-Vernejoul MC (1992) Bone mastocytosis. A report of nine cases with a bone histomorphometric study. Clin Orthop 279:281–291
Kalender WA, Felsenberg D, Louis O, et al (1989) Reference values for trabecular and cortical vertebral bone density in single and dual energy quantitative computed tomography. Eur J Radiol 9:75–80
Kluin-Nelemans HC, Jansen JG, Breukelman H, et al (1992) Response to interferon alfa-2B in a patient with systemic mastocytosis. N Engl J Med 326:619–623
Lorenz W, Duda D, Dick W, et al (1994) Incidence and clinical importance of perioperative histamine release: randomised study of volume loading and antihistamines after induction of anaesthesia. Lancet 343:933–940
Nafziger J, Arock M, Guillosson JJ, et al (1990) Specific high affinity receptors for interferon-gamma on mouse bone marrow-derived mast cells: inhibitory effect of interferon-gamma on mast cell precursors. Eur J Immunol 20:113–117
Parwaresch MR, Horny HP, Lennert K (1985) Tissue mast cells in health and disease. Pathol Res Pract 179:439–461
Talpaz M, Kantarjian H, Mccredie K, et al (1986) Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. N Engl J Med 314:1065–1069
Webb TA, Li CY, Yam LT (1982) Systemic mast cell disease: a clinical and haematopathological study of 26 cases. Cancer 49:927–938
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weide, R., Ehlenz, K., Lorenz, W. et al. Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b. Ann Hematol 72, 41–43 (1996). https://doi.org/10.1007/BF00663015
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00663015